From the quarterly, "In further support of these efforts in respect to the galidesivir opportunity, Island has engaged an organisation specialising in securing government funding and providing ongoing project management support to government funded programs."
this makes me think that cash on hand is maybe, enough to finish due diligence, but not enough to buy Galidesivir. interesting to see how much cash it will be to buy the rights to it.
also, looking at the animal rule a bit more - on the surface of it, it certainly looks like its a strong candidate.
I would suggest that human efficacy studies cannot be conducted because accidental or deliberate exposure to diseases like ebola, zika etc. would be unethical. However, because Galidesivir is a broad spectrum anti-viral, i don't know where it leaves approval and if only certain indications would be approved...
(20min delay)